Results 191 to 200 of about 413,499 (385)

Hypertrophic cardiomyopathy [PDF]

Current Problems in Cardiology, 1993
Maron, B J, McKenna, W J, Elliott, P, Spirito, P, Frenneaux, M P, Keren, A, Cecchi, F, Borggrefe, M, Williams, W G   +8 more
openaire   +7 more sources

Jamaican Cardiomyopathy [PDF]

, 1967
K. R. Hill, W.J.S. Still, B. McKinney
openalex   +1 more source

Book Review: Cardiomyopathies [PDF]

, 1965
Anne Dornhorst
openalex   +1 more source

Natural products targeting regulated cell deaths for adriamycin-induced cardiotoxicity

Cell Death Discovery
Adriamycin (ADR), as an anti-cancer drug in routine clinical application, is utilized to treat various cancers such as ovarian cancer, hematological malignant tumor, and endometrial carcinoma.
Zheng Wang, Yanli Zhu, Yu Yao, Wenyu Zhang, Bo Wang, Jing Wang, Yang Yang, Liwen Liu   +7 more
doaj   +1 more source

Identification of a novel titin-cap/telethonin mutation in a Portuguese family with hypertrophic cardiomyopathy

Revista Portuguesa de Cardiologia, 2020
Introduction and objectives: Hypertrophic cardiomyopathy (HCM) is a genetically and phenotypically heterogeneous disease; there is still a large proportion of patients with no identified disease-causing mutation.
Alexandra Toste, Andreas Perrot, Cemil Özcelik, Nuno Cardim   +3 more
doaj  

New concepts of intramural myocardial conduction in hypertrophic obstructive cardiomyopathy.

, 1968
J J Coyne
openalex   +1 more source

Histochemical, ultrastructural and structural changes in primary cardiomyopathy and in cobalt cardiomyopathy [PDF]

, 1972
E. G. J. Olsen
openalex   +1 more source

Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)

Clinical Pharmacology &Therapeutics, EarlyView.
Clinical inhibition and genetic variation of the Breast Cancer Resistance Protein (BCRP/ABCG2) efflux transporter can significantly influence drug exposure, highlighting the need for reliable BCRP functional biomarkers. This study aimed to identify and evaluate biomarkers predictive of BCRP function in humans.
Andrew M. Riselli, Sook Wah Yee, Jia Yang, Claire M. Brett, Kelsey Trumbach, Xujia Zhou, Renmeng Liu, Xiaomin Liang, Yurong Lai, Runlan Huo, Yongjun Xue, Hong Shen, Lei Zhang, Xinning Yang, Qi Liu, Shiew‐Mei Huang, Kathleen M. Giacomini   +16 more
wiley   +1 more source

Predicting in‐hospital mortality among patients admitted with a diagnosis of heart failure: a machine learning approach

ESC Heart Failure
Existing risk prediction models for hospitalized heart failure patients are limited. We identified patients hospitalized with a diagnosis of heart failure between 7 May 2013 and 26 April 2022 from a large academic, quaternary care medical centre ...
Zina Jawadi, Rosemary He, Pratyaksh K. Srivastava, Gregg C. Fonarow, Suzan O. Khalil, Srikanth Krishnan, Eleazar Eskin, Jeffrey N. Chiang, Ali Nsair   +8 more
doaj   +1 more source

Large-scale cross-modality pretrained model enhances cardiovascular state estimation and cardiomyopathy detection from electrocardiograms: An AI system development and multi-center validation study [PDF]

arXiv
Cardiovascular diseases (CVDs) present significant challenges for early and accurate diagnosis. While cardiac magnetic resonance imaging (CMR) is the gold standard for assessing cardiac function and diagnosing CVDs, its high cost and technical complexity limit accessibility.
arxiv